株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

分子診断・血液ドナースクリーニングの米国市場:2016年 (2022年までの予測)

US Market for Molecular Diagnostics and Blood Donor Screening - 2016 (Forecasted to 2022)

発行 iData Research Inc. 商品コード 344802
出版日 ページ情報 英文 104 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: iData Research社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
分子診断・血液ドナースクリーニングの米国市場:2016年 (2022年までの予測) US Market for Molecular Diagnostics and Blood Donor Screening - 2016 (Forecasted to 2022)
出版日: 2015年10月01日 ページ情報: 英文 104 Pages
概要

分子診断は、かつては極めて高度な訓練を受けた検査技師によって大規模なラボで実施されていましたが、マルチファンクションの実行・マルチアッセイの動作を可能にする自動システムが利用可能になったことで、経験の少ないスタッフを用いた小規模の病院および独立ラボにおいても急速に導入が広がっています。多くの小規模競合企業の参入による検査価格の低下、従来の検査方法 (微生物学および免疫測定法など) と比較した分子アッセイの高い特異性・感受性といった要因により、分子診断は今後の米国におけるIVD市場において優勢を保つと見られています。

当レポートでは、米国における分子診断・血液ドナースクリーニング市場について分析し、全体的な市場構造や近年の市場情勢・資本取引動向を調査すると共に、分野別の市場構造や市場規模の詳細動向を推計・考察しております。

目次

図表

第1章 エグゼクティブサマリー

第2章 調査手法

  • 調査範囲
  • IDATAの9段階の分析手法

第3章 分子診断市場

  • イントロダクション
  • 市場分析・予測
    • 分子診断装置市場
    • 分子診断アッセイキット市場全体
      • 感染症診断アッセイキット市場全体
        • 血液性ウィルス感染症アッセイキット市場全体
        • HIV
        • HCV
        • HBV
        • 女性医療用アッセイキット市場全体
        • HPV
        • HSV
        • CT/GC
        • その他感染症アッセイキット市場
        • MRSA
        • ディフィシル菌
        • CMV
      • 遺伝子診断アッセイキット市場全体
        • 嚢胞性線維症
        • 栓友病
      • 癌診断アッセイキット市場全体
        • 乳癌
        • 結腸直腸癌
        • 前立腺癌
  • 市場成長促進要因・抑制要因
    • 促進要因
    • 抑制要因
  • 競合分析

第4章 分子血液ドナースクリーニング市場

  • イントロダクション
  • 市場分析・予測
    • 分子血液ドナースクリーニングアナライザー市場
    • 分子血液ドナースクリーニングアッセイキット市場全体
      • WNV
      • HIV
      • HCV
      • HBV
      • 複合検査
  • 市場成長促進要因・抑制要因
    • 促進要因
    • 抑制要因
  • 競合分析

略語一覧

目次
Product Code: iDATA_USMDBD16_RPT

The US Molecular Diagnostics and Blood Donor Screening Market report contains Molecular Diagnostics Instrument Market, MDx Assay Kit Market, Infectious Disease Diagnostic Assay Kit Market, Genetic Diagnostics Assay Kit Market, and the Oncology Diagnostics Assay Kit Market. The Blood Donor Screening Market consists of the Molecular Blood Donor Screening Analyzer Market and Assay Kit Market.

The MDx market includes analytical systems and assays used for DNA (and RNA) extraction, amplification and detection. Systems can range from low throughput instruments such as thermal cyclers to high throughput automated systems. They may run on different technologies such as polymerase chain reaction (PCR), transcription mediated amplification (TMA) or gel electrophoresis. Tests may be used for identifying disease, for monitoring disease progression and effects of treatment or for predicting predisposition of individuals to various diseases. Revenues associated with companion diagnostic tests for therapeutic drugs or testing done using technologies such as Fluorescence In Situ Hybridization (FISH) or Next Generation Sequencing (NGS) are not included in this report.

Molecular diagnostics, once confined to large labs with highly trained laboratorians, is rapidly being adopted by smaller hospitals and independent labs with less skilled labor due to the following key factors: availability of automated systems capable of performing multiple functions and running multiple assays on a single platform, decreasing test prices owing to the entry of many smaller competitors, high specificity and sensitivity of molecular assays compared to other traditional testing methods (such as microbiology or immunoassays), and favorable FDA guidelines requiring new drug therapies to be tested for their efficacy on particular patient groups through associated companion diagnostic tests. All these factors will enable molecular diagnostics to continue its dominance in the U.S. IVD market in the future.

While Roche Diagnostics was the clear market leader for 2015 in the Molecular Diagnostics Assay Kit Market, they still were far behind Grifols USA within the Molecular Blood Donor Screening Market. More detailed information on these companies as well as Hologic, Myriad Genetics, Genomic Health, Cephied, Qiagen, Becton Dickinson, Abbott Diagnostics and many more are found in this 2 segment report.

This Report Also Includes:

  • In-depth, Professionally Researched Data That Has Been Formatted and Analyzed to Gain Actionable Insights as Quickly as Possible
  • Executive Summary
  • Trend Analysis by Segment
  • Market Value Forecasts until 2022 and History Back to 2012
  • Market Drivers and Limiters
  • Detailed Competitive Analysis for Each Market and Segment

To Get The Most of this report:

Combine it with our other US market reports on, Hematology, Hemostasis, Molecular Diagnostics, Blood Donor Screening, or Point of Care Diagnostic Devices.

iData Research Methodology - By utilizing a 9-Step Methodology we can ensure that we have the most accurate, up-to-date, and representative figures of the markets. Our data is collected with careful secondary research, and even more importantly our primary research, gathered through interviews and questionnaires with industry professionals, allows us the ability to perform analysis far beyond the initial numbers.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. MOLECULAR DIAGNOSTICS MARKET
  • 1.2. MOLECULAR BLOOD DONOR SCREENING MARKET

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

MOLECULAR DIAGNOSTICS MARKET

  • 3.1. INTRODUCTION
  • 3.2. MARKET ANALYSIS AND FORECAST
    • 3.2.1. Molecular Diagnostics Instrument Market
    • 3.2.2. Total Molecular Diagnostics Assay Kit Market
      • 3.2.2.1. Total Infectious Disease Diagnostic Assay Kit Market
        • 3.2.2.1.1. Total Blood Borne Virus Infectious Disease Assay Kit Market
        • 3.2.2.1.2. HIV Assay Kit Market
        • 3.2.2.1.3. HCV Assay Kit Market
        • 3.2.2.1.4. HBV Assay Kit Market
        • 3.2.2.1.5. Total Women's Health Assay Kit Market
        • 3.2.2.1.6. HPV Assay Kit Market
        • 3.2.2.1.7. HSV Assay Kit Market
        • 3.2.2.1.8. CT/GC Assay Kit Market
        • 3.2.2.1.9. Other Infectious Disease Assay Kit Market
        • 3.2.2.1.10. MRSA Assay Kit Market
        • 3.2.2.1.11. C. difficile Assay Kit Market
        • 3.2.2.1.12. CMV Assay Kit Market
      • 3.2.2.2. Total Genetic Diagnostics Assay Kit Market
        • 3.2.2.2.1. Cystic Fibrosis Assay Kit Market
        • 3.2.2.2.2. 40.2Thrombophilia Assay Kit Market
      • 3.2.2.3. Total Oncology Diagnostics Assay Kit Market
        • 3.2.2.3.1. Breast Cancer Assay Kit Market
        • 3.2.2.3.2. Colorectal Cancer Assay Kit Market
        • 3.2.2.3.3. Prostate Cancer Assay Kit Market
  • 3.3. DRIVERS AND LIMITERS
    • 3.3.1. Market Drivers
    • 3.3.2. Market Limiters
  • 3.4. COMPETITIVE ANALYSIS

MOLECULAR BLOOD DONOR SCREENING MARKET

  • 4.1. INTRODUCTION
  • 4.2. MARKET ANALYSIS AND FORECAST
    • 4.2.1. Molecular Blood Donor Screening Analyzer Market
    • 4.2.2. Total Molecular Blood Donor Screening Assay Kit Market
      • 4.2.2.1. WNV Assay Kit Market
      • 4.2.2.2. HIV Assay Kit Market
      • 4.2.2.3. HCV Assay Kit Market
      • 4.2.2.4. HBV Assay Kit Market
      • 4.2.2.5. Combined Test Assay Kit Market
  • 4.3. DRIVERS AND LIMITERS
    • 4.3.1. Market Drivers
    • 4.3.2. Market Limiters
  • 4.4. COMPETITIVE ANALYSIS

ABBREVIATIONS

Back to Top